Form 4 holding
Sr. VP and CFO
Protalix BioTherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 660,909
- Estimated value
- $931,882
- Report date
- 23 Sep 2024
- Price
- $1.41
- Ownership
- By Trust
Eyal Rubin - Sr. VP and CFO at Protalix BioTherapeutics, Inc.
Issuer-level insider activity
- Role
- Sr. VP and CFO
- Issuer ticker
- PLX on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Eyal Rubin since 05 Sep 2025
Reported holdings for Eyal Rubin in Protalix BioTherapeutics, Inc.
Transaction history for Eyal Rubin in Protalix BioTherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.